Cyclin e expression and prognosis in breast cancer patients: a meta-analysis of published studies.
about
Novel Molecular Markers for Breast CancerSublobectomy versus lobectomy for stage IA (T1a) non-small-cell lung cancer: a meta-analysis study.Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancerOverexpression of POLQ confers a poor prognosis in early breast cancer patients.Clinicopathological and prognostic significance of survivin over-expression in patients with esophageal squamous cell carcinoma: a meta-analysis.Impact of cyclin E overexpression on Smad3 activity in breast cancer cell linesNew castanospermine glycoside analogues inhibit breast cancer cell proliferation and induce apoptosis without affecting normal cellsPrognostic Value of Expression of Cyclin E in Gastrointestinal Cancer: A Systematic Review and Meta-Analysis.Tissue microarrays in clinical oncologyDifferences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells.Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohortAdjuvant chemotherapy in oesophageal cancer: a meta-analysis and experience from the Shanghai Cancer Hospital.CDK/CCN and CDKI alterations for cancer prognosis and therapeutic predictivity.Sublobectomy versus lobectomy for stage I non-small-cell lung cancer, a meta-analysis of published studies.Individualization of treatment strategies.Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature.Aberrant expression of cyclin E in low-risk node negative breast cancer.Overexpression of VEGF-C correlates with a poor prognosis in esophageal cancer patients.Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer.K(+) channels and cell cycle progression in tumor cells.Prognostic value of cyclin E expression in breast cancer: a meta-analysis.Cytoplasmic HuR expression correlates with P-gp, HER-2 positivity, and poor outcome in breast cancer.Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer.Survivin rs9904341 (G>C) polymorphism contributes to cancer risk: an updated meta-analysis of 26 studies.Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients.Cyclin E1 is a strong prognostic marker for death from lymph node negative breast cancer. A population-based case-control study.
P2860
Q26753160-CFC4592E-FFBE-40CC-9FED-2D3878AC3AA9Q33646142-6B8EA08B-41C4-4DF6-9992-2988E56DDE61Q33715865-4A4228B3-1462-4CAA-A0CC-440F45696908Q34051213-4B12B235-2379-47ED-91AC-98639592A99BQ34427388-AA9A6576-A913-4F6D-9AAE-CBE8203CC7E6Q34619813-3282C5E1-DE8D-4C25-A048-41EAB0D79419Q35016962-1F08DF77-7285-49EB-823E-FE1BFB0DE280Q35550222-8C1267F8-C6A5-4F77-A396-80F27C42B1F0Q36537565-57B993C4-99C0-4E95-AF33-C3976548DEDAQ36674327-AD4E017D-97EB-4715-9AF3-28B7BDD368CFQ36787362-A4D70D7B-775C-4BF6-84D4-8B7364A8FD5DQ37285198-3A82B9A1-1577-4CE5-9612-0E94936D92E5Q37586623-36D91AD4-9E3D-4393-AD0F-211CF2D7EF06Q37902547-96556D8D-3FC8-468B-B22E-1AE8C8852B0AQ37933161-2C77B185-F824-4832-9034-9C09E020F07AQ38051085-3EC5230D-5238-4E2E-85D8-C6A2E666E879Q39852495-AD0DC01D-E0C8-4A41-A8AA-A05FC8997E57Q40615441-3BBEC7E9-FA83-473E-AF8F-82D872225371Q40951473-8EAE2024-BBC6-4322-B789-C4530FE9FBB0Q41849048-149F7BC0-E068-4BAE-842E-C0E3640B852FQ45751455-2A0C3E5F-DE9B-48E8-89DB-273A4569F041Q51054802-7D96D52B-EA0C-412D-8154-490DBE802BD7Q52955581-243885E1-FFEB-491F-B11C-B37F58C1ED94Q53087859-3A1425BE-6484-48FE-B3AD-30B7A7D50BD5Q53285198-4A07E355-694D-45F4-ADB8-B95290D511FCQ54314758-05F58775-18FA-45F9-8C83-5E6BAB3A3FB5
P2860
Cyclin e expression and prognosis in breast cancer patients: a meta-analysis of published studies.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Cyclin e expression and progno ...... analysis of published studies.
@en
Cyclin e expression and progno ...... analysis of published studies.
@nl
type
label
Cyclin e expression and progno ...... analysis of published studies.
@en
Cyclin e expression and progno ...... analysis of published studies.
@nl
prefLabel
Cyclin e expression and progno ...... analysis of published studies.
@en
Cyclin e expression and progno ...... analysis of published studies.
@nl
P2860
P1433
P1476
Cyclin e expression and progno ...... analysis of published studies.
@en
P2093
Zhi-Ming Shao
P2860
P304
P356
10.1080/07357900600894799
P577
2006-10-01T00:00:00Z